EGFR and breast cancer: Consistent with a role for PDK1 in tumorigenesis, PDK1 overexpression and increased copy number in breast cancer has been shown to correlate with upstream lesions such as PTEN loss, PIK3CA mutation and EGFR amplification, and resulted in increased tumour growth, cell motility and poor prognosis13.